Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial

Human Reproduction
Trifon G LainasEfstratios M Kolibianakis

Abstract

Although initial studies in poor responders using GnRH antagonists have reported encouraging results, they are limited in number, only a few of them are prospective, while the majority is characterized by limited power to detect a clinically important difference. A randomized controlled trial was performed in patients with one or more previous failed IVF cycles in which five or less oocytes were retrieved, using > or =300 IU of gonadotrophins/day. Patients were randomized by computer-generated list and treated by either the flare-up GnRH agonist protocol (n = 90) or a flexible GnRH antagonist protocol (n = 180). Ongoing pregnancy rate, the primary outcome measure, was significantly higher in the antagonist group compared with the agonist group (12.2 versus 4.4%, P< 0.048; difference 7.8%, 95% CI: 0.2 to 14.0). Estradiol levels on the day of hCG administration were lower in the antagonist protocol [median (interquartile range): 572 (325-839) versus 727 (439-1029) pg/ml, P = 0.018]. Clinical and biochemical pregnancy rates, fertilization and implantation rates, as well as the number of oocytes retrieved, the number of mature oocytes present, the stimulation period and the gonadotrophin dosage were not significantly different betw...Continue Reading

Citations

Jan 12, 2011·Archives of Gynecology and Obstetrics·Mohammad Ali KarimzadehFatemeh Mansoori Moghaddam
Oct 1, 2013·Human Reproduction Update·Antonio La Marca, Sesh Kamal Sunkara
Mar 4, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Marta DevesaPedro N Barri
Apr 3, 2009·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Raffaella DepaloLuigi Selvaggi
Jan 25, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Yu SongBin Wang
Jan 24, 2012·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Tahereh MadaniLadan Mohammadi Yeganeh
Oct 1, 2014·International Journal of Molecular Sciences·Mahmoud HashemitabarRoshan Nikbakht
Oct 31, 2015·Systems Biology in Reproductive Medicine·Itai GatClifford L Librach
Feb 5, 2016·Human Reproduction Update·Athanasios PapathanasiouSiladitya Bhattacharya
May 13, 2011·Reproductive Biomedicine Online·Tarek A Gelbaya, Luciano G Nardo
Nov 17, 2009·Reproductive Biomedicine Online·Batuhan OzmenHülya Olmus
Apr 24, 2009·Journal de gynécologie, obstétrique et biologie de la reproduction·C BasilleN Frydman
Sep 16, 2010·Annals of the New York Academy of Sciences·Christos A VenetisBasil C Tarlatzis
Nov 9, 2010·Taiwanese Journal of Obstetrics & Gynecology·Robab DavarRazieh Dehghani Firouzabadi
Mar 3, 2012·Clinical and Experimental Reproductive Medicine·Chung-Hoon KimByung-Moon Kang
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Zabeena PandianSiladitya Bhattacharya
May 1, 2012·Expert Review of Endocrinology & Metabolism·Colin M HowlesRoy Homburg
Jul 11, 2020·Reproductive Biology and Endocrinology : RB&E·F M FusiA Di Pasqua
Sep 4, 2018·Frontiers in Endocrinology·Sandro C EstevesCarlo Alviggi
Jan 11, 2021·Archives of Gynecology and Obstetrics·Myrto PapamentzelopoulouPetros Drakakis
Aug 3, 2021·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Adem YavuzMurat Sonmezer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.